Invest In Innovation

Lumedica Vision offers a rare opportunity to invest in breakthrough eye care technology with the potential to transform global access to diagnostic imaging. Its affordable, portable Optical Coherence Tomography (OCT) systems enable early detection of vision-threatening diseases in primary care settings and underserved communities—places where traditional, high-cost imaging is often out of reach. By making advanced eye care more accessible, Lumedica is positioned to improve outcomes for millions worldwide while addressing a critical unmet medical need.

Backed by cutting-edge research from Duke University and significant non-dilutive NIH funding, Lumedica has validated both its innovation and commercial potential. The company holds strong intellectual property, a scalable business model, and broad market applicability across clinical, industrial, and research sectors. With clear demand and a defined path to commercialization, Lumedica represents a high-growth opportunity for mission-driven investors seeking to support impactful healthcare innovation with strong financial upside.